本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

Terns Pharmaceuticals, Inc.

4.32
+0.06001.41%
盘后4.23-0.0900-2.08%14:49 EDT
成交量:26.32万
成交额:113.03万
市值:3.77亿
市盈率:-4.00
高:4.36
开:4.30
低:4.21
收:4.26
数据加载中...
2024/11/12

员工持股计划

Form S-8 - Securities to be offered to employees in employee benefit plans
2024/11/12

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/11/12

重要事件披露

Form 8-K - Current report
2024/11/06

超过5%披露

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2024/09/16

超过5%披露

Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
2024/09/12

重要事件披露

Form 8-K - Current report
2024/09/10

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/09/10

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/09/09

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/09/09

重要事件披露

Form 8-K - Current report
2024/08/05

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/08/05

重要事件披露

Form 8-K - Current report
2024/07/30

重要事件披露

Form 8-K - Current report
2024/07/22

超过5%披露

Form SC 13G - Statement of Beneficial Ownership by Certain Investors
2024/07/18

超过5%披露

Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
2024/07/15

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/07/15

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/07/15

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/07/15

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/07/03

重要事件披露

Form 8-K - Current report